Mapping the landscape: a bibliometric study of global chimeric antigen receptor T cell immunotherapy research
W Zhang, W Wei, L Ma, H Du, A Jin, J Luo… - … Archives of Pharmacology, 2024 - Springer
The rise of immunotherapy provided new approaches to cancer treatment. We aimed to
describe the contribution of chimeric antigen receptor T cell immunotherapy to future …
describe the contribution of chimeric antigen receptor T cell immunotherapy to future …
[PDF][PDF] Investigation of the Effect of Low-positive HER-2 on Neoadjuvant Chemotherapy Response in Hormone-positive Breast Cancer Patients
Objective: Recently, it has been suggested that low-positive human epidermal growth factor
receptor-2 (HER-2) is a separate group of breast cancer. We examined the effect of low …
receptor-2 (HER-2) is a separate group of breast cancer. We examined the effect of low …